SKIN

8/14/2006 -- Reliant Launches Fraxel® SR1500 Laser
New Product with Optimized Spot Size and Advanced Dosage Control Expands Fraxel Family of Laser Products
MOUNTAIN VIEW, Calif., August 14, 2006--(Business Wire)--Reliant Technologies, Inc. today announced the launch of the Fraxel SR1500 laser, the latest innovation in aesthetic laser medical technology. The Fraxel SR1500 laser combines proprietary advancements in optical technology with medical software offering physicians a treatment option that penetrates up to 30 percent deeper, delivering consistent dosage control and optimizing lesion depths. This leap in technology provides patients a safe and effective, non-invasive treatment option for skin conditions ranging from mild sun damage to severe acne scarring. Click here for more of this release

8/14/2006 -- La Roche-Posay Announces FDA Approval of Mexoryl™ SX
Anthelios SX Daily Moisturizing Cream With Mexoryl™ SX Now Available to U.S. Consumers
NEW YORK, Aug. 14, 2006 (PRNewswire) -- La Roche-Posay announces that the U.S. Food and Drug Administration (FDA) has approved Anthelios SX with Mexoryl™ SX [ecamsule]. Anthelios SX SPF 15 is a new revolutionary daily moisturizing cream containing Mexoryl™ SX, a unique organic filter that is highly protective against short UVA waves. It is the first time the FDA has approved a new sunscreen filter since 1988! Click here for more of this release

3/27/2006 -- Reliant Technologies Announces FDA Clearance of the Fraxel® Laser for the Treatment of Acne and Surgical Scars
Physicians Report Fractional Laser Resurfacing Achieves Dramatic Improvement MOUNTAIN VIEW, Calif.--March 27, 2006--Reliant Technologies today announced that it has received U.S. Food and Drug Administration (FDA) clearance to market a new indication for its breakthrough Fraxel® Laser that enables physicians to treat acne scars and surgical scars. Until now, facial scarring has been difficult to treat with even the most aggressive topical and abrasive therapies. This has been a major disappointment to adult patients who must carry the stigma of adolescent acne long after their skin is free of active acne, or to those individuals who are left with a permanent reminder of a past surgery. Click here for more of this release

9/15/2005 -- ALLERGAN LAUNCHES PREVAGE™ MD ANTI-AGING TREATMENT CONTAINING THE MOST POTENT ANTIOXIDANT AVAILABLE IN A SKIN CARE PRODUCTbr> More than 70% of patients surveyed reported a reduction in the appearance of fine lines and wrinkles in four weeks
IRVINE, Calif. – September 21, 2005 – Allergan, Inc. today announced the launch of its newly formulated PREVAGE™ MD anti-aging treatment, which contains a clinically tested antioxidant shown to help correct the appearance of fine lines and wrinkles and protect against environmental factors including sun damage, air pollution and cigarette smoke. PREVAGE™ MD contains the highest concentration (one percent) of idebenone, the most potent antioxidant currently available in a skin care product. Click here for more of this release

7/27/2005 -- Reliant Technologies Announces FDA Clearance of FRAXEL™ Laser for the Treatment of Melasma
Embarrassing Skin Disorder Known As the Mask of Pregnancy Is Estimated To Affect Nearly 6 Million Women in the U.S.
PALO ALTO, Calif.--(Business Wire)--July 27, 2005--Reliant Technologies today announced that the U.S. Food and Drug Administration (FDA) has cleared its breakthrough FRAXEL™ Laser for the specific treatment of melasma, a disturbing skin pigmentation that presents as patterns of dark brown patches on the face and is associated with pregnancy, female hormonal activity and certain drugs. Until now, the stubborn skin condition has been resistant to available therapies, with traditional laser and pulsed light treatments considered unsatisfactory due to lackluster results, significant downtime or the risk of adverse complications...."With the Fraxel laser's unique approach of using millions of microscopic thermal spots to gently resurface only portions of skin at a time, we can now penetrate deep enough to eliminate the melanocytes that cause melasma." Click here for more of this release